Literature DB >> 1127596

Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites.

S Yolles, T D Leafe, J H Woodland, F J Meyer.   

Abstract

Parallel in vitro and in vivo release rates of tritiated naltrexone from poly(lactic acid) composites were studied. The in vitro release of naltrexone was 67% of the dose over a 35-day test period, while the in vivo release was only 24% within 70 days. Apparently, an exchange of the tritium for the hydrogen of the body water takes place, indicating that urinary excretion radioactivity is not a reliable measure for estimating the naltrexone released. Naltrexone-poly(lactic acid) composites showed effective blocking action to morphine in rats (24 days), dogs (29 days), monkeys (20 days), and mice (21 days).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127596     DOI: 10.1002/jps.2600640239

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

Review 1.  PLA micro- and nano-particles.

Authors:  Byung Kook Lee; Yeonhee Yun; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2016-06-01       Impact factor: 15.470

2.  Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management.

Authors:  Albert Stuart Reece
Journal:  Subst Abuse       Date:  2012-09-27

3.  Novel PEG-graft-PLA nanoparticles with the potential for encapsulation and controlled release of hydrophobic and hydrophilic medications in aqueous medium.

Authors:  Bin Wang; Weimin Jiang; Hao Yan; Xiaoxi Zhang; Li Yang; Lihong Deng; Gurinder K Singh; Jun Pan
Journal:  Int J Nanomedicine       Date:  2011-07-07

4.  RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin.

Authors:  Jie Xu; Ji-Hui Zhao; Ying Liu; Nian-Ping Feng; Yong-Tai Zhang
Journal:  Int J Nanomedicine       Date:  2012-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.